Recent reviews of data related to this indicate some pain relief but no conclusive evidence as of yet that it can slow or reverse progression of disease. Here is what one recent study concluded:

Meanwhile, because limited data is available to demonstrate the neuroprotective effects of HBOT in humans, newly designed clinical trials are needed on HBOT’s neuroprotection and its possible mechanisms as well as the course and dose of HBOT.